[ad_1]
Source: Abanoub Sami – launch news
A group of scientists at the Mbadachusetts Institute of Technology has found a way to use genetically engineered bacteria to treat liver and bowel diseases by removing toxins from the intestine.
Leading technical researchers have developed a type of common bacterium to eliminate excess ammonia in the body, dangerous for people with liver damage and rare genetic disorders.
"The new drug, based on modified microbes, designed by Cenlogic in cooperation with the Mbadachusetts Institute of Technology, can reduce dangerous levels of ammonia in the body by converting it to arginine, an amino acid, thus increasing the chances survival of patients.
The researchers found in the laboratory experiment that the mice that received the drug called SYNB1020 decreased the amount of ammonia in the blood, which bodes better for survival after liver damage and genetic strikes.
A little experiment on healthy people has also revealed that the bacteria work as expected and are safe.
"These data show that we can design bacteria for them to successfully fulfill a specific function in the human body," said Paul Miller, chief scientist at Sinologik.
[ad_2]
Source link
